Sudden cardiac death from the perspective of coronary artery disease

Mayo Clinic Proceedings

Volumn 89, Issue 12, 2014, Pages 1685-1698

  Sara, Jaskanwal D ^a   Eleid, Mackram F ^a   Gulati, Rajiv ^a   Holmes, David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CHOLESTEROL; COCAINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; NITRIC ACID DERIVATIVE; PLACEBO; SIMVASTATIN; SPIRONOLACTONE; VASOCONSTRICTOR AGENT; VASOPRESSIN; ZOFENOPRIL;

ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; AUTOMATED EXTERNAL DEFIBRILLATOR; BLOOD FLOW; BRADYCARDIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAPHY; EXERCISE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; INDUCED HYPOTHERMIA; ISCHEMIC HEART DISEASE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; NONSUSTAINED VENTRICULAR TACHYCARDIA; OUTPATIENT CARE; PATHOGENESIS; PREVALENCE; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN CARDIAC DEATH; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; COMPLICATION; DEATH, SUDDEN, CARDIAC; HEART; MORTALITY; OUT-OF-HOSPITAL CARDIAC ARREST; PATHOPHYSIOLOGY; RISK FACTOR;

CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART; HUMANS; MYOCARDIAL INFARCTION; OUT-OF-HOSPITAL CARDIAC ARREST; RISK FACTORS;

EID: 84919665635     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.08.022     Document Type: Review

References (108)

1. R.J. Myerburg, K.M. Kessler, and A. Castellanos Sudden cardiac death: epidemiology, transient risk, and intervention assessment Ann Intern Med 119 12 1993 1187 1197
2. R.J. Myerburg, and A. Castellanos Cardiac arrest and sudden cardiac death E. Braunwald, Heart Disease: A Textbook of Cardiovascular Medicine 5th ed. 1997 WB Saunders Philadelphia, PA 742 779
3. M.A. el Fawal, G.A. Berg, D.J. Wheatley, and W.A. Harland Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions Br Heart J 57 4 1987 329 335
4. J.J. de Vreede-Swagemakers, A.P. Gorgels, and W.I. Dubois-Arbouw Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival J Am Coll Cardiol 30 6 1997 1500 1505
5. S.W. Carveth, D. Olson, and J. Bechtel Emergency medical care system: Lincoln (Neb) mobile heart team Arch Surg 108 4 1974 528 530
6. L. Vertesi The paramedic ambulance: a Canadian experience Can Med Assoc J 119 1 1978 25 29
7. J.W. Bachman, G.S. McDonald, and P.C. O'Brien A study of out-of-hospital cardiac arrests in northeastern Minnesota JAMA 256 4 1986 477 483
8. L.B. Becker, D.W. Smith, and K.V. Rhodes Incidence of cardiac arrest: a neglected factor in evaluating survival rates Ann Emerg Med 22 1 1993 86 91
9. E.D. Engelstein, and D.P. Zipes Sudden cardiac death R.W. Alexander, R.C. Schlant, V. Fuster, Hurst's The Heart, Arteries and Veins 9th ed. 1998 McGraw-Hill New York, NY 1081 1112
10. E.C. Stecker, K. Reinier, and E. Marijon Public health burden of sudden cardiac death in the United States Circ Arrhythm Electrophysiol 7 2 2014 212 217
11. A.C. Thomas, P.A. Knapman, D.M. Krikler, and M.J. Davies Community study of the causes of "natural" sudden death BMJ 297 6661 1988 1453 1456
12. I.H. Leach, J.W. Blundell, J.M. Rowley, and D.R. Turner Acute ischaemic lesions in death due to ischaemic heart disease: an autopsy study of 333 cases of out-of-hospital death Eur Heart J 16 9 1995 1181 1185
13. D.P. Zipes, and H.J. Wellens Sudden cardiac death Circulation 98 21 1998 2334 2351
14. P. Théroux, and V. Fuster Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction Circulation 97 12 1998 1195 1206
15. A.P. Burke, A. Farb, G.T. Malcom, Y. Liang, J. Smialek, and R. Virmani Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women Circulation 97 21 1998 2110 2116
16. M.J. Davies, and A. Thomas Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death N Engl J Med 310 18 1984 1137 1140
17. A. Farb, A.L. Tang, A.P. Burke, L. Sessums, Y. Liang, and R. Virmani Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction Circulation 92 7 1995 1701 1709
18. E. Patterson, K. Holland, B.T. Eller, and B.R. Lucchesi Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction: a conscious canine model of sudden coronary death Am J Cardiol 50 6 1982 1414 1423
19. R.D. Hurt, S.A. Weston, and J.O. Ebbert Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws Arch Intern Med 172 21 2012 1635 1641
20. M.J. Davies, J.M. Bland, J.R. Hangartner, A. Angelini, and A.C. Thomas Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death Eur Heart J 10 3 1989 203 208
21. K.S. Reddy, and S. Yusuf Emerging epidemic of cardiovascular disease in developing countries Circulation 97 6 1998 596 601
22. P.G. Milner, E.V. Platia, P.R. Reid, and L.S. Griffith Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest Am J Cardiol 56 10 1985 588 592
23. S.S. Chugh, K.L. Kelly, and J.L. Titus Sudden cardiac death with apparently normal heart Circulation 102 6 2000 649 654
24. B.B. Lerman, B. Dong, K.M. Stein, S.M. Markowitz, J. Linden, and D.F. Catanzaro Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2 J Clin Invest 101 12 1998 2862 2868
25. S.G. Priori, J. Barhanin, and R.N. Hauer Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III Circulation 99 5 1999 674 681
26. S.G. Priori, J. Barhanin, and R.N. Hauer Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II Circulation 99 4 1999 518 528
27. A. Bayés de Luna, P. Coumel, and J.F. Leclercq Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases Am Heart J 117 1 1989 151 159
28. L.A. Cobb, C.E. Fahrenbruch, M. Olsufka, and M.K. Copass Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000 JAMA 288 23 2002 3008 3013
29. R.J. Myerburg, H. Halperin, and D.A. Egan Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop Circulation 128 23 2013 2532 2541
30. M. Hulleman, J. Berdowski, and J.R. de Groot Implantable cardioverter-defibrillators have reduced the incidence of resuscitation for out-of-hospital cardiac arrest caused by lethal arrhythmias Circulation 126 7 2012 815 821
31. S.T. Youngquist, A.H. Kaji, and J.T. Niemann Beta-blocker use and the changing epidemiology of out-of-hospital cardiac arrest rhythms Resuscitation 76 3 2008 376 380
32. K.O. Akosah, A. Schaper, C. Cogbill, and P. Schoenfeld Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 41 9 2003 1475 1479
33. N.J. Stone, J.G. Robinson, and A.H. Lichtenstein 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25, suppl 2 2014 S1 S45
34. M.K. Reriani, A.J. Flammer, A. Jama, L.O. Lerman, and A. Lerman Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome Circ J 76 4 2012 778 783
35. S.J. Lester, M.F. Eleid, B.K. Khandheria, and R.T. Hurst Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis Mayo Clin Proc 84 3 2009 229 233
36. M.F. Eleid, S.J. Lester, and T.L. Wiedenbeck Carotid ultrasound identifies high risk subclinical atherosclerosis in adults with low Framingham risk scores J Am Soc Echocardiogr 23 8 2010 802 808
37. Y.S. Ali, K.E. Rembold, and B. Weaver Prediction of major adverse cardiovascular events by age-normalized carotid intimal medial thickness Atherosclerosis 187 1 2006 186 190
38. L.E. Chambless, G. Heiss, and A.R. Folsom Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am J Epidemiol 146 6 1997 483 494
39. Y.G. Yap, T. Duong, and J.M. Bland Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction - a combined analysis from multicenter trials Clin Cardiol 28 10 2005 471 478
40. Y.G. Yap, T. Duong, and J.M. Bland Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction Heart 93 7 2007 832 836
41. G. Wannamethee, A.G. Shaper, P.W. Macfarlane, and M. Walker Risk factors for sudden cardiac death in middle-aged British men Circulation 91 6 1995 1749 1756
42. W.B. Kannel, D.R. Gagnon, and L.A. Cupples Epidemiology of sudden coronary death: population at risk Can J Cardiol 6 10 1990 439 444
43. A. Algra, J.G. Tijssen, J.R. Roelandt, J. Pool, and J. Lubsen Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death Circulation 88 1 1993 180 185
44. A.G. Shaper, G. Wannamethee, P.W. Macfarlane, and M. Walker Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men Br Heart J 70 1 1993 49 55
45. G. Zuanetti, J.M. Neilson, R. Latini, E. Santoro, A.P. Maggioni, D.J. Ewing GISSI-2 Investigators Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era: the GISSI-2 results Circulation 94 3 1996 432 436
46. M.T. La Rovere, J.T. Bigger Jr., F.I. Marcus, A. Mortara, P.J. Schwartz ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction Lancet 351 9101 1998 478 484
47. H. Aberg, H. Lithell, I. Selinus, and H. Hedstrand Alcohol intemperance and social disability as risk factors for different causes of death Acta Med Scand 220 4 1986 351 359
48. M. Flesch, S. Rosenkranz, E. Erdmann, and M. Böhm Alcohol and the risk of myocardial infarction Basic Res Cardiol 96 2 2001 128 135
49. P.E. Ronksley, S.E. Brien, B.J. Turner, K.J. Mukamal, and W.A. Ghali Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis BMJ 342 2011 d671
50. E.B. Rimm, P. Williams, K. Fosher, M. Criqui, and M.J. Stampfer Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors BMJ 319 7224 1999 1523 1528
51. S.E. Brien, P.E. Ronksley, B.J. Turner, K.J. Mukamal, and W.A. Ghali Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies BMJ 342 2011 d636
52. J. Lucena, M. Blanco, and C. Jurado Cocaine-related sudden death: a prospective investigation in south-west Spain Eur Heart J 31 3 2010 318 329
53. B.S. Benzaquen, V. Cohen, and M.J. Eisenberg Effects of cocaine on the coronary arteries Am Heart J 142 3 2001 402 410
54. J.A. Kors, M.C. de Bruyne, and A.W. Hoes T-loop morphology as a marker of cardiac events in the elderly J Electrocardiol 31 suppl 1998 54 59
55. E.G. Schouten, J.M. Dekker, P. Meppelink, F.J. Kok, J.P. Vandenbroucke, and J. Pool QT interval prolongation predicts cardiovascular mortality in an apparently healthy population Circulation 84 4 1991 1516 1523
56. M. Zabel, T. Klingenheben, M.R. Franz, and S.H. Hohnloser Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study Circulation 97 25 1998 2543 2550
57. L.H. Curtis, T. Ostbye, and V. Sendersky Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients Am J Med 114 2 2003 135 141
58. A.P. Maggioni, G. Zuanetti, and M.G. Franzosi Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results Circulation 87 2 1993 312 322
59. A.I. Mushlin, W.J. Hall, J. Zwanziger MADIT Investigators The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT Circulation 97 21 1998 2129 2135
60. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, G. Hafley Multicenter Unsustained Tachycardia Trial Investigators A randomized study of the prevention of sudden death in patients with coronary artery disease [published correction appears in N Engl J Med. 2000;342(17):1300] N Engl J Med 341 25 1999 1882 1890
61. D. Lloyd-Jones, R.J. Adams, T.M. Brown American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2010 update: a report from the American Heart Association [published corrections appear in Circulation. 2010;121(12):e260 and Circulation. 2011;124(16):e425] Circulation 121 7 2010 e46 e215
62. M.L. Weisfeldt, S. Everson-Stewart, C. Sitlani Resuscitation Outcomes Consortium Investigators Ventricular tachyarrhythmias after cardiac arrest in public versus at home N Engl J Med 364 4 2011 313 321
63. T.D. Valenzuela, D.J. Roe, G. Nichol, L.L. Clark, D.W. Spaite, and R.G. Hardman Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos N Engl J Med 343 17 2000 1206 1209
64. S.L. Caffrey, P.J. Willoughby, P.E. Pepe, and L.B. Becker Public use of automated external defibrillators N Engl J Med 347 16 2002 1242 1247
65. R.D. Macdonald, J.M. Swanson, J.L. Mottley, and C. Weinstein Performance and error analysis of automated external defibrillator use in the out-of-hospital setting Ann Emerg Med 38 3 2001 262 267
66. B.T. Stolzenberg, D.F. Kupas, B.J. Wieczorek, and D.P. Sole Automated external defibrillators appropriately recognize ventricular fibrillation in electromagnetic fields Prehosp Emerg Care 6 1 2002 65 66
67. D.P. Zipes Sudden cardiac death: future approaches Circulation 85 1, suppl 1992 I160 I166
68. R.J. Van Hoeyweghen, L.L. Bossaert, A. Mullie Belgian Cerebral Resuscitation Study Group Quality and efficiency of bystander CPR Resuscitation 26 1 1993 47 52
69. R. Swor, I. Khan, R. Domeier, L. Honeycutt, K. Chu, and S. Compton CPR training and CPR performance: do CPR-trained bystanders perform CPR? Acad Emerg Med 13 6 2006 596 601
70. V.J. De Maio, I.G. Stiell, D.W. Spaite Ontario Prehospital Advanced Life Support (OPALS) Study Group CPR-only survivors of out-of-hospital cardiac arrest: implications for out-of-hospital care and cardiac arrest research methodology Ann Emerg Med 37 6 2001 602 608
71. B. Lynch, E.L. Einspruch, G. Nichol, L.B. Becker, T.P. Aufderheide, and A. Idris Effectiveness of a 30-min CPR self-instruction program for lay responders: a controlled randomized study Resuscitation 67 1 2005 31 43
72. V. Wenzel, A.C. Krismer, H.R. Arntz, H. Sitter, K.H. Stadlbauer, K.H. Lindner European Resuscitation Council Vasopressor during Cardiopulmonary Resuscitation Study Group A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation N Engl J Med 350 2 2004 105 113
73. P.Y. Gueugniaud, J.S. David, and E. Chanzy Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation N Engl J Med 359 1 2008 21 30
74. R.W. Neumar, C.W. Otto, and M.S. Link Part 8: adult advanced cardiovascular life support; 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [published corrections appear in Circulation. 2013;128(25):e480 and Circulation. 2011;123(6):e236] Circulation 122 18, suppl 3 2010 S729 S767
75. Hypothermia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest [published correction appears in N Engl J Med. 2002;346(22):1756] N Engl J Med 346 8 2002 549 556
76. S.A. Bernard, T.W. Gray, and M.D. Buist Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia N Engl J Med 346 8 2002 557 563
77. D. Yannopoulos, M. Zviman, and V. Castro Intra-cardiopulmonary resuscitation hypothermia with and without volume loading in an ischemic model of cardiac arrest Circulation 120 14 2009 1426 1435
78. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 8478 1986 397 402
79. R.G. Wilcox, G. von der Lippe, C.G. Olsson, G. Jensen, A.M. Skene, J.R. Hampton Anglo-Scandinavian Study of Early Thrombolysis Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study Lancet 335 8699 1990 1175 1178
80. I.S.A.M. Study Group A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days N Engl J Med 314 23 1986 1465 1471
81. AIMS Trial Study Group Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study Lancet 335 8687 1990 427 431
82. G.W. Stone, C.L. Grines, D. Rothbaum PAMI Trial Investigators Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial J Am Coll Cardiol 29 5 1997 901 907
83. S.G. Priori, E. Aliot, and C. Blomstrom-Lundqvist Task Force on Sudden Cardiac Death of the European Society of Cardiology [published correction appears in Eur Heart J. 2002;23(3):257] Eur Heart J 22 16 2001 1374 1450
84. R.W. Jeremy, R.A. Hackworthy, G. Bautovich, B.F. Hutton, and P.J. Harris Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction J Am Coll Cardiol 9 5 1987 989 995
85. G. Pizzetti, G. Belotti, A. Margonato, A. Cappelletti, and S.L. Chierchia Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction J Am Coll Cardiol 28 4 1996 837 845
86. G.W. Stone, B.R. Brodie, J.J. Griffin Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial J Am Coll Cardiol 31 1 1998 23 30
87. L. Maillard, M. Hamon, K. Khalife STENTIM-2 Investigators A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction J Am Coll Cardiol 35 7 2000 1729 1736
88. A.J. Moss, W.J. Hall, D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial Investigators Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 26 1996 1933 1940
89. E. Ambrosioni, C. Borghi, B. Magnani Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction N Engl J Med 332 2 1995 80 85
90. M.A. Pfeffer, E. Braunwald, L.A. Moyé SAVE Investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial N Engl J Med 327 10 1992 669 677
91. B. Pitt, F. Zannad, W.J. Remme Randomized Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 10 1999 709 717
92. Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 19 1998 1349 1357
93. Scandinavian Simvastatin Survival Study (4S) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease Lancet 344 8934 1994 1383 1389
94. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [published correction appears in BMJ. 2002;324(7330):141] BMJ 324 7329 2002 71 86
95. P.C. Elwood, and P.M. Sweetnam Aspirin and secondary mortality after myocardial infarction Lancet 2 8156-8157 1979 1313 1315
96. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 5 1985 335 371
97. P. Held Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects Am J Cardiol 71 9 1993 39C 44C
98. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 9266 2001 1385 1390
99. M.J. Domanski, D.V. Exner, C.B. Borkowf, N.L. Geller, Y. Rosenberg, and M.A. Pfeffer Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials J Am Coll Cardiol 33 3 1999 598 604
100. J.C. LaRosa, J. He, and S. Vupputuri Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials JAMA 282 24 1999 2340 2346
101. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients [published correction appears in Lancet. 1994;343(8899):742] Lancet 343 8893 1994 311 322
102. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 8607 1988 349 360
103. C.H. Hennekens, C.M. Albert, S.L. Godfried, J.M. Gaziano, and J.E. Buring Adjunctive drug therapy of acute myocardial infarction - evidence from clinical trials N Engl J Med 335 22 1996 1660 1667
104. W.D. Weaver, R.J. Simes, and A. Betriu Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review [published correction appears in JAMA. 1998;279(23):1876] JAMA 278 23 1997 2093 2098
105. F.I. Marcus, L.A. Cobb, and J.E. Edwards Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction Am J Cardiol 61 1 1988 8 15
106. S.H. Hohnloser, T. Klingenheben, M. Zabel, M. Schöpperl, and O. Mauss Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era J Am Coll Cardiol 33 7 1999 1895 1902
107. D.J. Statters, M. Malik, S. Redwood, K. Hnatkova, A. Staunton, and A.J. Camm Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era Am J Cardiol 77 2 1996 133 138
108. S.H. Hohnloser, P. Franck, T. Klingenheben, M. Zabel, and H. Just Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era: a prospective trial Circulation 90 4 1994 1747 1756